Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 19/20 | 0.50 |
| ▸ | PPARA | Q07869 | 17/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 6/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6619532 | 0.93 | PPARG (0.52) | PPARGPPARAFFAR1PPARD | |
| SCHEMBL6616076 | 0.93 | KDM4E (0.51) | PPARGPPARAFFAR1PPARD | |
| SCHEMBL6614426 | 0.89 | PPARG (0.48) | PPARGPPARAPPARD | |
| SCHEMBL6616267 | 0.88 | PPARG (0.51) | PPARGPPARAPPARD | |
| SCHEMBL6614323 | 0.87 | PPARG (0.52) | PPARGPPARAPPARD | |
| SCHEMBL6616433 | 0.80 | PPARG (0.54) | PPARGPPARAPPARD | |
| SCHEMBL6816032 | 0.78 | PPARG (0.57) | PPARGPPARAFFAR1PPARD | |
| SCHEMBL6618124 | 0.78 | PPARG (0.50) | PPARGPPARAPPARD | |
| SCHEMBL4393183 | 0.77 | PPARG (0.60) | PPARGPPARAFFAR1PPARD | |
| SCHEMBL4391342 | 0.76 | PPARG (0.59) | PPARGPPARAFFAR1PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1423363-A1 | ORAL ANTIDIABETIC AGENTS | Warner-Lambert Company LLC (US) | 2004-06-02 | — | — | EP | claimed |
| WO-2003018553-A1 | ORAL ANTIDIABETIC AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2003-03-06 | — | — | WO | claimed |
| EP-1423363-A1 | ORAL ANTIDIABETIC AGENTS | Warner-Lambert Company LLC (US) | 2004-06-02 | — | — | EP | disclosed |
| WO-2003018553-A1 | ORAL ANTIDIABETIC AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2003-03-06 | — | — | WO | disclosed |